Fate Therapeutics Inc. buy Mizuho
Start price
20.11.23
/
50%
€2.37
Target price
20.11.24
€7.31
Performance (%)
-14.58%
End price
21.11.24
€2.03
Summary
This prediction ended on 21.11.24 with a price of €2.03. The price of Fate Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.58%. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | -3.377% | -3.377% | 13.084% |
| iShares Core DAX® | -3.640% | -8.784% | -0.694% |
| iShares Nasdaq 100 | -2.986% | -1.710% | 11.948% |
| iShares Nikkei 225® | -3.000% | -9.097% | 23.387% |
| iShares S&P 500 | -2.389% | -2.781% | 7.620% |
Comments by Mizuho for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target lowered by analysts at Mizuho from $12.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten